Medical Devices · Healthcare
CEO
Equibles does not estimate personal net worth.
Get an email with a short summary when Sensus Healthcare, Inc. publishes a filing, an earnings call transcript or a press release.
Get SRTS alertsJoseph Sardano is recorded as CEO at Sensus Healthcare, Inc. (SRTS). The newest filing on record that lists Joseph Sardano as CEO at Sensus Healthcare, Inc. (SRTS) is dated April 29, 2026. The proxy statement of Sensus Healthcare, Inc. reports total compensation of $1,417,860 for Joseph Sardano in fiscal 2025, including a base salary of $600,000. Disclosed compensation is on record for 8 fiscal years. Joseph Sardano has spoken on 9 earnings calls across 1 company, most recently for Sensus Healthcare, Inc. on February 12, 2026. Sensus Healthcare, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Sensus Healthcare, Inc. includes Arthur Levine (CFO), Javier Rampolla (CFO), Magdalena Martinez (COO) and 5 others.
“Let me start by providing some context around our end-of-year activities and the wonderful news received from CMS. SRT and IGSRT are non-invasive technology that was exclusively designed, developed, and distributed by Census Healthcare.”
“Before we jump into the meat of today's call, let me address the distribution of our earnings news release earlier today. As you know, we typically issue our financial announcements after the markets close.”
“Our sales momentum continued in the second quarter of 2024 with very strong year-over-year revenue growth, along with positive net income and positive adjusted EBITDA.”
“I'm delighted to report excellent results for Q1 2024. Sensus Healthcare has seen some very positive momentum. And as the dermatology community recognizes the importance of IG-SRT to their patients and their practices as a noninvasive and highly efficacious modality to treat non-melanoma skin cancer.”
“Our second quarter financial results showed improvement over the first quarter. During Q2, we shipped 13 systems, including four SRT systems outside the US, and six SRT-100 Vision systems up from 10 systems shipped during the first quarter of 2023, but down from 33 systems shipped in the prior year quarter.”
Start not stated–present
Last confirmed April 29, 2026
Medical Devices · Healthcare
CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Sensus Healthcare, Inc. (SRTS) | Chief Executive Officer | $600,000 | $1,417,860 |
| 2024 | Sensus Healthcare, Inc. (SRTS) | Chief Executive Officer | $500,000 | $1,268,030 |
| 2023 | Sensus Healthcare, Inc. (SRTS) | Chief Executive Officer | $450,000 | $687,599 |
| 2022 | Sensus Healthcare, Inc. (SRTS) | Chief Executive Officer | $400,000 | $754,428 |
| 2021 | Sensus Healthcare, Inc. (SRTS) | Chief Executive Officer | $375,000 | $628,451 |
| 2020 | Sensus Healthcare, Inc. (SRTS) | Chief Executive Officer | $375,000 | $510,006 |
| 2019 | Sensus Healthcare, Inc. (SRTS) | Chief Executive Officer | $375,000 | $466,800 |
| 2018 | Sensus Healthcare, Inc. (SRTS) | Chief Executive Officer | $360,000 | $538,392 |